深潮 TechFlow 消息,7 月 1 日,港股上市公司领航医药生物科技有限公司(00399)宣布签署谅解备忘录,计划收购一家目标公司的全部股权,前提是该目标公司完成对Conflux区块链相关资产的收购。收购对价将通过现金、公司股份或可换股债券支付,具体金额待定。谅解备忘录有效期为12个月,期间卖方不得与第三方就目标公司股权进行谈判。此举旨在帮助领航医药拓展区块链技术业务,实现业务多元化并寻找新的盈利增长点。交易尚需签署正式协议后方可落实。
Navigating Web3 tides with focused insights
Contribute An Article
Media Requests
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / support@techflowpost.com ICP License: 琼ICP备2022009338号




